At a glance
ClinicalIndex Comparison RecordN/ACompleted· 334 enrolled
Drug / intervention
ALGOS Systemother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Expanded Development of a Medical Device Utilizing an EEG-Based Algorithm for the Objective Quantification of Pain
In Brief
An observational study evaluating ALGOS System for Chronic Pain. Completed, enrolled 334 participants across 5 sites.
Detailed Summary
PainQx is conducting a study to collect electroencephalography (EEG) data from 250 people with chronic pain and 50 healthy controls in order to develop algorithms that will objectively assess the level of pain a person is experiencing.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJul 2020
First PostedOct 2020
Primary CompletionJan 2022
TodayJul 2026
First PostedOct 14, 2020
Enrollment StartJul 23, 2020
Primary CompletionJan 5, 2022
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 5.7 years ago
Interventions
ALGOS Systemother
A Quantitative Electroencephalography (QEEG) based pain biomarker assessment that scales with patient reported Numeric Rating Scale (NRS)